Shop Research About Compliance Affiliate Free Consultation
Hot

Retatrutide

LY3437943 · GLP-1/GIP/Glucagon Triple Agonist

★★★★★4.8 out of 5(127 reviews)

Triple-agonist GLP-1/GIP/glucagon receptor agonist. Most studied compound in metabolic research.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Ships in 24hr ✓ US-Based ✓ Direct Support
📋 Certificate of Analysis — RT5 View third-party COA PDF for 5mg
Retatrutide research peptide vial
Select Size
$150
10-vial kit
+ $40 shipping · Free over $500 · Ships worldwide
✓ Added to cart View Cart →
Research Data

What Is Retatrutide?

Retatrutide (LY3437943) is a GIP/GLP-1/glucagon triple receptor co-agonist in Phase 3 clinical investigation. Phase 2 NEJM data (2023) demonstrated up to 24.2% mean body weight reduction at 48 weeks, the highest reported for any incretin-class compound.

Research Context

  • Triple receptor agonism (GLP-1/GIP/glucagon) as a metabolic research model
  • Adiposity reduction and body composition in clinical trial populations
  • Hepatic lipid metabolism and NAFLD pathway modulation
  • Comparative receptor pharmacology vs dual agonists and monoagonists
  • Glucagon receptor contribution to energy expenditure

Storage & Reconstitution

Store lyophilized at -20°C for 12–24 months. Reconstituted in BAC water: refrigerate at 2–8°C, use within 4–6 weeks.

All products sold for research purposes only. Not for human or animal consumption. Must be 18+ to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.